Alzheimer DiseaseMILLSNCT05530590

Minnesota Inclusive LTSS for LGBTQ Seniors

A study testing Training to Serve (TTS) in person training and Training to Serve online training (eTTS) in people with Alzheimer Disease and Dementia, run by University of Minnesota at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

Who is it for?: Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for: Alzheimer Disease, Dementia
What is being tested?: Training to Serve (TTS) in person training and Training to Serve online training (eTTS)
Type of treatment: Pill or oral medicine
Could I receive a placebo?: No, everyone receives an active treatment
How many people: 761 participants
Where: 1 siteUnited States
Study dates: 31 Jan 2024to 12 Dec 2025
Phase: Interventional
Are there results?: None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 18 years and older
All sexes
Healthy volunteers accepted
Adult, Older adult

Who may be able to join

licensure in Minnesota to provide nursing and/or as a housing with services establishment
Willingness to undertake a policy and environment review at baseline and 6 months later
having at least 5 managers/ supervisors and 5 staff.

Who cannot join

Participants who cannot speak and read English

Trial locations and contacts

1 site in 1 country.

United States1 site

University of Minnesota
Minneapolis, Minnesota, 55455

Other trials in United States

About this study

Official title: Training the Long-Term Services and Supports Dementia Care Workforce in Provision of Care to Sexual and Gender Minority Residents

This study is designed to help improve the care of sexual and gender minority (SGM) with Alzheimer's Disease and Alzheimer's Disease Related Dementia (AD/ADRD) in long-term services and supports (LTSS) by training the state's LTSS workforce in SGM culturally responsive care. The randomized controlled trial will rigorously test the effects of an in person versus an online training program on improving SGM culturally responsive care with a waitlist control.

Read the detailed description

The study involves conducting a 3-arm, stratified (management/staff), group (agency) randomized controlled trial (RCT) of the in-person vs. online intervention vs. waitlist control on organizational factors (i.e., environment and policy) and on staff knowledge, attitudes, and skills.

Conditions: Alzheimer Disease, Dementia
Being tested: Training to Serve (TTS) in person training, Training to Serve online training (eTTS)
Keywords: Long-term support and service facilities, Alzheimer Disease, Dementia, LTSS, Seniors
Medical subject headings: Alzheimer Disease, Dementia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Training to Serve (TTS) in person trainingOther
Participants receive in person training.
Training to Serve online training (eTTS)Other
Participants receive online training.

Study groups in NCT05530590
Study group	Role	What they receive
Training to Serve (TTS) in person training	Experimental	Participants are provided access to the pretest one week before the training. On the day of training, when the trainers arrive, participants have a final opportunity to complete the baseline survey before the intervention. Tablets will be available to complete pre- and post- surveys. The training for management takes 3-4 hours, and for staff, one hour. For consistency and feasibility, both trainings are conducted by the same trainers at the same visit. Immediately after the intervention, participants complete the post-intervention seminar evaluation assessing knowledge and attitudes/comfort in serving SGM clients. Receives: Other: Training to Serve (TTS) in person training
Training to Serve online training (eTTS)	Experimental	Participants are provided a unique identifier to access the online website. The opening page welcomes them to the study, then directs them to the chunked consent materials and baseline survey. As soon as they have completed this, they receive access to the intervention, which for management is expected to take 1-2 hours and for staff, 30-45 minutes (i.e., the online equivalent of 3-4 and 1 hour, respectively). After completion of the required modules, participants receive access to the optional modules as well as the posttest survey to evaluate the training. Once the post-test is complete, they are thanked for their involvement and informed they will receive an e-mail to access a follow-up survey in six months' time. Receives: Other: Training to Serve online training (eTTS)
Waitlist control	No intervention	Participants complete the baseline survey, then they receive a note thanking them for completing all activities and informing them the intervention will be available in 6 months' time.

What is being measured

The primary outcome is the main question the study is designed to answer.

Environment change
Access to sexual and gender minority (SGM) providers, gender neutral intake forms
Measured: baseline and 6-months follow up
Skills assessment
Ability to conduct 7 skills key to providing competent care to SGM
Measured: Baseline
Skills assessment
Ability to conduct 7 skills key to providing competent care to SGM
Measured: Immediately post-intervention
Competence in SGM Care
Competent scale when it comes to providing care to SGM
Measured: 6 months after intervention

Secondary outcomes (11)

SGM with AD/ADRD referenced explicitly in policies
Human Resources policies and intake forms
Measured: Baseline
SGM with AD/ADRD referenced explicitly in policies
HR policies and intake forms
Measured: 6 months post-intervention
SGM knowledge
10-item review of key content in training
Measured: Baseline
SGM knowledge
10-item review of key content in training
Measured: immediately post-intervention
SGM knowledge
10-item review of key content in training
Measured: 6 months post-intervention
SGM attitudes
Homonegativity scale
Measured: Baseline
SGM attitudes
Homonegativity scale
Measured: immediately post-intervention
SGM attitudes
Homonegativity scale
Measured: 6 months post-intervention
Health care empathy
Jefferson Physician Empathy student version
Measured: Baseline
Health care empathy
Jefferson Physician Empathy student version
Measured: immediately post-intervention
Health care empathy
Jefferson Physician Empathy student version
Measured: 6 months post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

31 Jan 202412 Dec 2025

First posted7 Sep 2022
Study start31 Jan 2024
Primary completion12 Dec 2025
Study completion12 Dec 2025

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Other trials for Alzheimer DiseaseStudies of the same condition, open and under way.
More trials run by University of MinnesotaThe sponsor's other registered studies.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Interventional
Phase: Phase N/A
Primary purpose: Other
Allocation: Randomised
Intervention model: Parallel groups
Model description: The study involves conducting a 3-arm, stratified (management/staff), group (agency) randomized controlled trial (RCT) of the in-person vs. online intervention vs. waitlist control on organizational factors (i.e., environment and policy) and on staff knowledge, attitudes, and skills.
Masking: None (open label)
Enrolment: 761 participants (actual)

IDs, dates and publications

ClinicalTrials.gov ID: NCT05530590
Sponsor's protocol ID: STUDY00014177
Other IDs: 5R01AG075734
Acronym: MILLS
Status last verified: Apr 2026
First submitted: 22 Jul 2022
Last updated: 29 Apr 2026
Results posted: No
FDA-regulated drug: No
FDA-regulated device: No
Individual data sharing: No

Want to know more?

The sponsor has not listed a contact. The official record may have more details.

Talk to your doctor first and take this page with you. Only the study team can confirm whether you can join.

Questions to ask the study team

What is the study trying to find out?
What would I need to do, and how often would I visit?
Could I receive a placebo instead of the treatment?
What are the possible risks and benefits for me?
Will it cost me anything? Are travel or time paid for?
Can I keep seeing my own doctor during the study?
What happens when the study ends?

See locations

RecruitingPhase 2
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Alzheimer's Disease
Not yet recruiting
Acupressure as Long-term Intervention to Slow the Progression of Early/Mild Alzheimer's Disease
Alzheimer's Disease
RecruitingObservational study
Effectiveness and Safety of Disease-Modifying Therapy for Alzheimer's Disease: A Multicenter Retrospective Study
Alzheimer's Disease (AD)
RecruitingPhase 3
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Alzheimer Disease
RecruitingPhase 3
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
Alzheimer's Disease

All Alzheimer Disease trials

Study at a glance

From the registry record, last updated by the sponsor on 29 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: Training the Long-Term Services and Supports Dementia Care Workforce in Provision of Care to Sexual and Gender Minority Residents
ClinicalTrials.gov ID: NCT05530590
Acronym / sponsor ID: MILLS / STUDY00014177
Conditions: Alzheimer Disease, Dementia
Keywords: Long-term support and service facilities, Alzheimer Disease, Dementia, LTSS, Seniors
Study type: Interventional
Recruitment status: Completed
Enrolment: 761 participants (actual)
Lead sponsor: University of MinnesotaUniversity, hospital or other
Collaborators: National Institute on Aging (NIA)
Study start: 31 Jan 2024 (actual)
Primary completion: 12 Dec 2025 (actual)
Study completion: 12 Dec 2025 (actual)
First posted: 7 Sep 2022 (actual)
Results: Not posted in the source record

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

Detailed description

Study design

Primary purpose: Other
Allocation: Randomised
Intervention model: Parallel groups
Masking: None (open label)
Number of arms: 3
Model description: The study involves conducting a 3-arm, stratified (management/staff), group (agency) randomized controlled trial (RCT) of the in-person vs. online intervention vs. waitlist control on organizational factors (i.e., environment and policy) and on staff knowledge, attitudes, and skills.

Arm	Type	Receives
Training to Serve (TTS) in person training	Experimental	Other: Training to Serve (TTS) in person trainingParticipants are provided access to the pretest one week before the training. On the day of training, when the trainers arrive, participants have a final opportunity to complete the baseline survey before the intervention. Tablets will be available to complete pre- and post- surveys. The training for management takes 3-4 hours, and for staff, one hour. For consistency and feasibility, both trainings are conducted by the same trainers at the same visit. Immediately after the intervention, participants complete the post-intervention seminar evaluation assessing knowledge and attitudes/comfort in serving SGM clients.
Training to Serve online training (eTTS)	Experimental	Other: Training to Serve online training (eTTS)Participants are provided a unique identifier to access the online website. The opening page welcomes them to the study, then directs them to the chunked consent materials and baseline survey. As soon as they have completed this, they receive access to the intervention, which for management is expected to take 1-2 hours and for staff, 30-45 minutes (i.e., the online equivalent of 3-4 and 1 hour, respectively). After completion of the required modules, participants receive access to the optional modules as well as the posttest survey to evaluate the training. Once the post-test is complete, they are thanked for their involvement and informed they will receive an e-mail to access a follow-up survey in six months' time.
Waitlist control	No intervention	–Participants complete the baseline survey, then they receive a note thanking them for completing all activities and informing them the intervention will be available in 6 months' time.

Who may qualify

Ages: 18 years and older
Sex: All
Healthy volunteers: Accepted
Age groups: Adult, Older adult

Key inclusion criteria (3 listed)

licensure in Minnesota to provide nursing and/or as a housing with services establishment
Willingness to undertake a policy and environment review at baseline and 6 months later
having at least 5 managers/ supervisors and 5 staff.

Key exclusion criteria (1 listed)

Participants who cannot speak and read English

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Interventions

Intervention	Type	Arms
Training to Serve (TTS) in person trainingParticipants receive in person training.	Other	Training to Serve (TTS) in person training
Training to Serve online training (eTTS)Participants receive online training.	Other	Training to Serve online training (eTTS)

Primary outcome

Environment change
Time frame: baseline and 6-months follow up
Access to sexual and gender minority (SGM) providers, gender neutral intake forms
Skills assessment
Time frame: Baseline
Ability to conduct 7 skills key to providing competent care to SGM
Skills assessment
Time frame: Immediately post-intervention
Ability to conduct 7 skills key to providing competent care to SGM
Competence in SGM Care
Time frame: 6 months after intervention
Competent scale when it comes to providing care to SGM

11 secondary outcomes

SGM with AD/ADRD referenced explicitly in policies
Time frame: Baseline
SGM with AD/ADRD referenced explicitly in policies
Time frame: 6 months post-intervention
SGM knowledge
Time frame: Baseline
SGM knowledge
Time frame: immediately post-intervention
SGM knowledge
Time frame: 6 months post-intervention
SGM attitudes
Time frame: Baseline
SGM attitudes
Time frame: immediately post-intervention
SGM attitudes
Time frame: 6 months post-intervention
Health care empathy
Time frame: Baseline
Health care empathy
Time frame: immediately post-intervention
Health care empathy
Time frame: 6 months post-intervention

Results and safety

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 29 Apr 2026.
Individual participant dataSharing planned: No

Related trials for Alzheimer Disease

RecruitingPhase 2
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Alzheimer's Disease
Not yet recruiting
Acupressure as Long-term Intervention to Slow the Progression of Early/Mild Alzheimer's Disease
Alzheimer's Disease
RecruitingObservational study
Effectiveness and Safety of Disease-Modifying Therapy for Alzheimer's Disease: A Multicenter Retrospective Study
Alzheimer's Disease (AD)
RecruitingPhase 3
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Alzheimer Disease
RecruitingPhase 3
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
Alzheimer's Disease

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

Simon Rosser, PhD,MPH principal investigator

University of Minnesota

Tetyanna Shippee, PhD principal investigator

University of Minnesota

1 site in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Environment change (time frame: baseline and 6-months follow up). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05530590.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Apr 2026.